|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-03
|
$342,938
|
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Web-based Physical Activity Intervention for Children with ALL
|
5R01CA193478-02
|
$869,905
|
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
|
2K12CA167540-06
|
$807,997
|
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
|
1U24CA209837-01A1
|
$632,875
|
|
SHOGHI, KOORESH
|
WASHINGTON UNIVERSITY
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
Validating the protein binding domain of replication protein A as a cancer target
|
5R01CA174887-04
|
$325,775
|
|
FESIK, STEPHEN
|
VANDERBILT UNIVERSITY
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-03
|
$394,823
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Unraveling Genetic Determinants of Lung Cancer Risk in African Americans
|
5K07CA172294-06
|
$160,123
|
|
ALDRICH, MELINDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
|
1R01CA181671-01A1
|
$348,844
|
|
SHAO, JIEYA
|
WASHINGTON UNIVERSITY
|
|
Understanding Long Tail Driver Mutations in Cancer
|
1R01CA204749-01A1
|
$392,078
|
|
TAYLOR, BARRY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
|
5R01CA198089-03
|
$663,135
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Underlying Mechanisms in Angiosarcoma
|
5R01CA197943-03
|
$352,275
|
|
IRUELA-ARISPE, M
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
1R01CA204969-01A1
|
$332,357
|
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN
|
|
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
|
2R01CA154451-04A1
|
$498,703
|
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer
|
1R01CA209818-01A1
|
$470,010
|
|
MINKO, TAMARA
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$9,496
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Treatment and Outcomes in Diabetic Breast Cancer Patients
|
5R01CA188353-03
|
$406,860
|
|
GOLD, HEATHER
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Transcriptional Mechanisms of Tumor Suppression
|
5R01CA190558-03
|
$354,563
|
|
VERZI, MICHAEL
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
5R01CA197336-02
|
$407,748
|
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-33
|
$570,788
|
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
TIP60-chromatin interactions at DNA double-strand breaks
|
5F30CA196115-03
|
$30,917
|
|
LI, LONGYIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery
|
1R01CA209888-01A1
|
$617,907
|
|
WILLMANN, JUERGEN
|
STANFORD UNIVERSITY
|
|
Therapeutic Irradiation and Brain Functions
|
1R01CA213441-01
|
$382,297
|
|
ROSI, SUSANNA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-09
|
$3,203,095
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-02
|
$2,300,000
|
$322,000
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The targeting of the HIF switch in kidney cancer
|
7R01CA181106-04
|
$404,838
|
|
KOH, MEI YEE
|
UNIVERSITY OF UTAH
|
|
The role of RHOA G17V mutation in peripheral t-cell lymphomas
|
5R01CA197945-03
|
$366,000
|
|
PALOMERO, TERESA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel
|
5R01CA154986-05
|
$342,375
|
|
STILES, BANGYAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The role of PLAG1 in Wilms tumor formation
|
1K08CA207849-01A1
|
$157,185
|
$157,185
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The role of microRNA in oncogene-induced senescence and cancer development
|
5R01CA172115-05
|
$321,625
|
|
SUN, PEIQING
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas
|
5K08CA194162-03
|
$168,264
|
|
SCHNEPP, ROBERT
|
EMORY UNIVERSITY
|
|
The role of Lin28/let 7 pathway in Wilms' tumor
|
5F99CA212487-02
|
$31,994
|
$31,994
|
YERMALOVICH, ALENA
|
HARVARD UNIVERSITY
|
|
The Role of IDH1 Mutations in Gliomagenesis and Metabolism
|
5R01CA140316-07
|
$377,625
|
|
YAN, HAI
|
DUKE UNIVERSITY
|
|
The role of histone chaperone Asf1 in Alternative Lengthening of Telomeres
|
5R01CA174942-05
|
$402,550
|
|
KARLSEDER, JAN
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
The Role of ATM in Suppression of Lymphomas
|
2R01CA158073-06A1
|
$380,000
|
|
ZHA, SHAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-05
|
$327,850
|
|
CHEN, JIANJUN
|
UNIVERSITY OF CINCINNATI
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$6,131
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$1,734
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$2,384
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$145,970
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Regulation of Cisplatin resistance in ovarian cancer
|
5R01CA184717-04
|
$328,888
|
|
ZHU, WENGE
|
GEORGE WASHINGTON UNIVERSITY
|
|
The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair
|
5R01CA138835-08
|
$317,509
|
|
GREENBERG, ROGER
|
UNIVERSITY OF PENNSYLVANIA
|
|
The PI3K/AKT Pathway Regulates Histone H3 Modification
|
1K99CA204601-01A1
|
$136,080
|
|
SPANGLE, JENNIFER
|
DANA-FARBER CANCER INST
|
|
The identification of genetic determinants of melanoma recurrence
|
5R01CA187060-03
|
$484,247
|
|
KIRCHHOFF, TOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
THE EPIGENETIC ROLE OF THE NOVEL LONG NONCODING RNA, LCAL5, IN LUNG CANCER
|
1R03CA215372-01
|
$76,250
|
|
WHITE, NICOLE
|
WASHINGTON UNIVERSITY
|
|
The DARC side of Breast Cancer
|
1R21CA210237-01A1
|
$175,313
|
|
DAVIS, MELISSA
|
UNIVERSITY OF GEORGIA
|
|
The CXCR3 Chemokine System in Cancer Immunotherapy
|
1R01CA204028-01A1
|
$439,649
|
|
LUSTER, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine
|
1U24CA215109-01
|
$1,694,395
|
|
PRIOR, FRED
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer
|
5R01CA199004-03
|
$511,177
|
|
MOR, GIL
|
YALE UNIVERSITY
|
Total relevant funding to Wilm's Tumor for this search: $4,673,401
|